نتائج البحث

An Open-Label, Multicenter, Expanded Access Study of Oral AMN 107 in Adult Patients With Imatinib (Glivec®/Gleevec®_ - Resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase

• Authors : Dr. Naeem A. Chaudhri, Principal Investigator

• Source: An Open-Label, Multicenter, Expanded Access Study of Oral AMN 107 in Adult Patients With Imatinib (Glivec®/Gleevec®_ - Resistant or

تفاصيل العنوان

Study of Imatinib (Glivec) in Patients With Adenoid Cystic Carcinoma of the Head and Neck

• Source: Phase II Study of Imatinib (Glivec) Administered as a Daily Oral Treatment in Patients With Recurrent/Metastatic Adenoid Cystic Carcinoma

تفاصيل العنوان

Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec®, Gleevec™)

• Authors : Martin Henkes; Heiko van der Kuip; Walter E Aulitzky

Subjects: Therapeutics. Pharmacology; RM1-950

• Source: Therapeutics and Clinical Risk Management, Vol 2008, Iss Issue 1, Pp 163-187 (2008)

تفاصيل العنوان

La declaratoria de interés público del medicamento Imatinib - Glivec, configura un responsabilidad internacional

• Authors : Neira Cardona, Sandra Liliana; Robayo Galvis, Wilfredo

Subjects: Patentes de invención - Aspectos jurídicos; Medicamentos-patentes; marcas

تفاصيل العنوان

Molecular monitoring of response to imatinib (Glivec®) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission.

• Authors : Paschka, P.¹; Müller, M.C.¹; Merx, K.¹

• Source: Leukemia (08876924). Sep2003, Vol. 17 Issue 9, p1687. 8p.

تفاصيل العنوان

JS-K, a glutathione S-transferase-activated nitric oxide donor, enhances imatinib (Glivec) cytotoxicity in malignant gliomas in vitro

Subjects: glioma; nitric oxide; imatinib

• Source: 58. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie e.V. (DGNC); 20070426-20070429; Leipzig; DOCFR.09.08 /20070411/

تفاصيل العنوان

JS-K, a glutathione S-transferase-activated nitric oxide donor, enhances imatinib (Glivec) cytotoxicity in malignant gliomas in vitro

Subjects: glioma; nitric oxide; imatinib

• Source: 58. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie e.V. (DGNC); 20070426-20070429; Leipzig; DOCFR.09.08 /20070411/

تفاصيل العنوان

Untersuchungen von Resistenzmechanismen und Prognosefaktoren bei Philadelphia Chromosom positiver akuter lymphatischer Leukämieund Blastenkrise bei chronischer myeloischer Leukämie unter derTherapie mit dem Tyrosinkinaseinhibitor Imatinib (Glivec®)

Subjects: ddc:610; doctoralthesis; doc-type:doctoralthesis

تفاصيل العنوان

Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec®, Gleevec™)

Subjects: Therapeutics and Clinical Risk Management; Review; info:eu-repo/semantics/article

تفاصيل العنوان

Clinical phase I/II trial to assess antitumor activity and tolerability of dacarbazine i.v. plus Imatinib (Glivec) orally in patients with metastatic malignant melanoma

Subjects: ddc: 610; conferenceObject

• Source: 27. Deutscher Krebskongress; 20060322-20060326; Berlin; DOCPO613 /20060320/

تفاصيل العنوان